Tonix Pharma

Tonix Pharma

Tonix Pharma

Millions of Americans suffer from central nervous system (CNS) disorders. Tonix Pharmaceuticals is developing medicines to help. $TNXP
Type
B2b
Raised
$8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$8,000,000
Post-IPO equity - 2017
Team Size
1–10
Employees
$8,000,000 Post-IPO equity
biospace

Tonix Pharma Completes 8 Million Public Offering Of Common Stock